Release Date: 24/04/18 09:20 Summary: Appendix 4C (Quarterly Reporting) - March 2018 Price Sensitive: Yes Download Document 175.22KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status